TENEDINI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 11.979
AS - Asia 6.248
EU - Europa 5.952
SA - Sud America 848
AF - Africa 195
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 15
Totale 25.295
Nazione #
US - Stati Uniti d'America 11.758
GB - Regno Unito 1.836
SG - Singapore 1.782
CN - Cina 1.560
IT - Italia 1.170
VN - Vietnam 751
HK - Hong Kong 744
BR - Brasile 603
SE - Svezia 603
DE - Germania 512
FR - Francia 345
RU - Federazione Russa 307
FI - Finlandia 269
TR - Turchia 254
KR - Corea 209
UA - Ucraina 193
IN - India 185
CA - Canada 137
ID - Indonesia 126
IE - Irlanda 101
BG - Bulgaria 84
NL - Olanda 81
BD - Bangladesh 75
JP - Giappone 70
PL - Polonia 69
AR - Argentina 68
IQ - Iraq 66
IR - Iran 65
PK - Pakistan 61
SI - Slovenia 61
ZA - Sudafrica 61
ES - Italia 58
MX - Messico 55
AU - Australia 54
BE - Belgio 47
EC - Ecuador 42
AE - Emirati Arabi Uniti 41
CL - Cile 41
CO - Colombia 40
LT - Lituania 29
CZ - Repubblica Ceca 28
SA - Arabia Saudita 28
MA - Marocco 27
TW - Taiwan 27
MY - Malesia 25
EG - Egitto 23
KE - Kenya 22
UZ - Uzbekistan 22
AT - Austria 20
VE - Venezuela 20
QA - Qatar 19
RO - Romania 18
IL - Israele 17
NP - Nepal 16
CH - Svizzera 15
NO - Norvegia 15
PT - Portogallo 15
TH - Thailandia 15
TN - Tunisia 14
HU - Ungheria 13
PH - Filippine 13
DZ - Algeria 12
AZ - Azerbaigian 11
KG - Kirghizistan 11
PE - Perù 11
MD - Moldavia 8
AL - Albania 7
BO - Bolivia 7
CI - Costa d'Avorio 7
GR - Grecia 7
MO - Macao, regione amministrativa speciale della Cina 7
RS - Serbia 7
UY - Uruguay 7
DK - Danimarca 6
EU - Europa 6
MK - Macedonia 6
MN - Mongolia 6
PY - Paraguay 6
SY - Repubblica araba siriana 6
XK - ???statistics.table.value.countryCode.XK??? 6
BH - Bahrain 5
CR - Costa Rica 5
HR - Croazia 5
KZ - Kazakistan 5
OM - Oman 5
PA - Panama 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
GH - Ghana 4
IS - Islanda 4
JM - Giamaica 4
NZ - Nuova Zelanda 4
A2 - ???statistics.table.value.countryCode.A2??? 3
JO - Giordania 3
KW - Kuwait 3
NG - Nigeria 3
SN - Senegal 3
TT - Trinidad e Tobago 3
Totale 25.249
Città #
Southend 1.303
Singapore 1.124
Ashburn 1.115
Fairfield 1.066
Santa Clara 1.043
Hong Kong 703
Chandler 670
Woodbridge 656
San Jose 539
Houston 483
Seattle 390
Ann Arbor 385
Hefei 384
Wilmington 338
Beijing 332
Nyköping 322
Cambridge 319
Dearborn 298
Jacksonville 297
London 253
Chicago 248
Modena 237
Council Bluffs 235
Ho Chi Minh City 220
Los Angeles 213
Hanoi 176
Seoul 174
Helsinki 166
New York 163
The Dalles 142
Izmir 106
Dublin 97
Munich 97
Jakarta 96
Salt Lake City 96
San Diego 89
Sofia 83
Lauterbourg 82
Princeton 79
Moscow 76
Shanghai 72
Eugene 68
Milan 66
Frankfurt am Main 65
Tampa 62
Buffalo 60
Bologna 59
Dallas 59
Fremont 58
Elk Grove Village 57
Dong Ket 55
Redwood City 54
Orem 52
São Paulo 52
Bremen 45
Falls Church 44
Des Moines 41
Warsaw 39
Brussels 38
Turku 38
Montreal 37
Tokyo 37
Rome 36
Guangzhou 33
Da Nang 31
Johannesburg 30
Toronto 30
Baghdad 28
Haiphong 28
Boardman 27
Lancaster 27
Istanbul 26
Columbus 25
Phoenix 23
Sterling 23
Atlanta 22
Denver 22
Melbourne 22
Parma 22
Amsterdam 21
Quito 21
Florence 20
Santiago 20
Rio de Janeiro 19
Stockholm 19
Falkenstein 18
Nuremberg 18
Biên Hòa 17
Brasília 17
Brno 17
Chennai 17
Doha 17
Kent 17
Las Vegas 17
Miami 17
Ottawa 17
Paris 17
Reggio Emilia 17
Ankara 16
Detroit 16
Totale 16.883
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 552
A Next Generation Sequencing amplicon-based strategy to explore Inherited Retinal Degeneration complexity 521
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 500
c-Myb supports erythropoiesis by transactivating KLF1 and LMO2 expression 463
New modulated genes in psoriasis-derived keratinocyte subpopulations. 462
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 454
Embryonic stem-derived versus somatic neural stem cells: A comparative analysis of their developmental potential and molecular phenotype 448
The barley Frost resistance-H2 locus 441
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 418
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Hybrid Posters 396
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells 393
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 389
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 388
ANALISYS OF GENE EXPRESSION PROFILE DURING MYOGENESIS EVIDENCES DIFFERENT MOLECULAR DEFECTS AT THE BASIS OF FSHD-1 AND FSHD-2 PATHOGENESIS 384
ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences. 377
Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity 372
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 363
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 360
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 356
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 356
Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells 354
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 351
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 346
No Identical ‘‘Mesenchymal Stem Cells’’ at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels 341
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 340
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 327
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 323
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 322
Tfe3 expression is closely associated to macrophage terminal differentiation of human hematopoietic myeloid precursors. 322
Hereditary pancreatic cancer: A retrospective single-center study of 5143 Italian families with history of BRCA-related malignancies 320
WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis 318
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 313
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 311
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 311
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 309
Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: focus on DNA repair genes 300
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 295
Brca detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: When biology overcomes genealogy 295
HGM 2010 Programme / Abstract 288
DIAGNOSI MOLECOLARE DELLE IPERTRIGLICERIDEMIE PRIMITIVE ATTRAVERSO “NGS” (NEXT GENERATION SEQUENCING) 285
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 283
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 281
Identification of new p63 targets in human keratinocytes 280
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-miR-299-5p in CD34+ progenitor cells commitment 278
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells 277
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 273
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 270
Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns 266
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 264
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 264
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 255
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 254
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 251
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 249
Abnormal expression of WT1-as, MEG3 and ANRIL long non-coding RNAs in primary myelofibrosis and their clinical correlates 246
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING MULTI-GENE PANEL 244
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING (NGS) MULTI-GENE PANEL 242
CXCR3 identifies human naive CD8+ T cells with enhanced effector differentiation potential 242
Wisp2 overexpression induced by short Teriparatide treatment affects IDG-SW3 osteogenic differentiation. 239
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation 235
Osteocytes signaling events induced by intermittent vs continuous Teriparatide treatment affect in vitro osteoblast differentiation and mineralization 233
Characterization of new ATM deletion associated with hereditary breast cancer 231
MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response 230
Clinical application of NGS in the diagnosis of iron overload disorders or hyperferritinemia of genetic origin 229
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 221
Gene Expression profile of Vitamin D3 treated HL60 cells shows a phenotypic but not a complete functional conversion to monocytes 216
Workload measurement for molecular genetics laboratory: A survey study 215
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 215
The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta 207
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 204
Gene expression Profile of Human Myeloid Cells 203
Survival features of EBV-stabilized cells from centenarians: morpho-functional and transcriptomic analyses. 203
Physiological levels of 1 alpha, 25 di-hydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors 202
Ivar, an interpretation‐oriented tool to manage the update and revision of variant annotation and classification 201
Liver Aging in Transplantation: Future Perspective on Donor-Recipient Age-Mismatch 199
P2X7 receptor activity limits accumulation of T cells within tumors 185
Management of PALB2-associated breast cancer: A literature review and case report 181
Constitutional Mosaicism: A Critical Issue in the Definition of BRCA-Inherited Cancer Risk 180
Requirement of the coiled coil domains of p92c-Fes for nuclear translocation in myeloid cells upon induction of differentiation 174
Targeting exhausted cytotoxic T cells through CTLA‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts 163
Pre-existing cytopenia heralding de novo acute myeloid leukemia: Uncommon presentation of NPM1-mutated AML in a single-center study 161
LOW-FREQUENCY ALLELE VARIANTS IN NGS MULTI-GENE PANELS FOR HEREDITARY CANCER TESTING: ARTIFACTS, CHIP OR MOSAICS? MANAGING THE RESULTS IN THE LABORATORY ROUTINE 153
Automation of a capture-based NGS workflow: one thousand patients experience in a diagnostic clinical routine framework 150
Clinically relevant low-frequency Next Generation Sequencing variants in hereditary cancer patients: an operational multi-step algorithm for laboratory managing 148
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-mir- 299-5p in CD34+ progenitor cells commitment 144
Detection of germline variants in 450 breast/ovarian cancer families with a multi‐gene panel including coding and regulatory regions 143
Homologous recombination deficiency in pancreatic neuroendocrine tumors 125
Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndrome 118
The prognostic and predictive role of somatic brca mutations in ovarian cancer: Results from a multicenter cohort study 110
Characterization of copy number variants in hereditary cancer patients through NGS shows a distinctive PALB2 contribution to the diagnostic yield 92
Diagnostic Yield and Clinical Impact of a Small Genetic Panel for Kidney Disease: A Multicenter, Retrospective European Study 88
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer 17
Totale 25.498
Categoria #
all - tutte 88.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.855


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021671 0 0 0 0 0 0 0 0 0 268 170 233
2021/20221.859 120 192 197 102 80 135 107 75 166 179 302 204
2022/20232.167 252 261 233 213 195 269 43 198 299 18 105 81
2023/20241.505 45 82 105 132 214 142 230 190 32 49 99 185
2024/20254.750 159 72 117 264 882 699 365 327 450 259 556 600
2025/20267.996 606 363 603 955 1.556 613 1.184 459 855 802 0 0
Totale 25.498